This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 2.55% to $688.08 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 2.77% to 4,271.78 and Dow Jones Industrial Average falling 2.82% to 33,811.40. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $59.34 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.99% to $181.54, Novartis AG ADR (NOVN.EB) fell 0.82% to $89.21, and Amgen Inc. (AMGN) fell 2.00% to $250.35. Trading volume (609,374) remained 55,939 below its 50-day average volume of 665,313.
Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2022.
(END) Dow Jones Newswires
April 22, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.